Vitiligo on the Scalp: Hair, Treatment, and What to Expect
Vitiligo on the scalp presents differently to vitiligo elsewhere on the body — not because the underlying mechanism is different, but because the scalp is covered in hair. This creates distinct practical challenges: the depigmentation may be invisible until hair is parted, white hair patches may be the first noticeable sign, and applying phototherapy to a hair-covered scalp requires specific technique.
What scalp vitiligo looks like
The depigmented patches of scalp vitiligo are identical in nature to patches elsewhere — melanocyte loss producing white skin. But because the scalp is covered in hair, the skin itself is often not the most visible feature. Instead, scalp vitiligo most commonly presents as white hair patches — areas where hair grows in completely without pigment.
This white hair (leukotrichia) happens because the hair follicles in the affected area have also lost their melanocytes. Scalp hair gets its colour from melanocytes located at the base of each follicle. When vitiligo destroys these cells, the hair grows in white. The skin beneath is also depigmented, but unless hair is parted to reveal the scalp, the white skin may not be immediately apparent.
The leukotrichia problem
White hair patches are not just cosmetically significant — they matter for prognosis. Hair follicles are the primary reservoir of melanocytes from which repigmentation occurs. The perifollicular dots that appear as early signs of treatment response come from surviving melanocytes migrating out from follicles.
When follicular melanocytes are destroyed (as evidenced by white hair), the reservoir for repigmentation in that area is significantly depleted. This is why scalp vitiligo with extensive leukotrichia has a worse prognosis for repigmentation than vitiligo elsewhere with intact pigmented follicles.
Partial leukotrichia — some hairs white, some still pigmented in the patch area — is a better sign. It suggests surviving follicular melanocytes that treatment may be able to activate.
Intersection with alopecia areata
Scalp vitiligo and alopecia areata (autoimmune hair loss) frequently co-occur. Both are autoimmune conditions; both show elevated rates in patients with one of the conditions compared to the general population. When a patient has both, the scalp presentation can be complex — white hair patches in some areas (vitiligo), bald patches in others (alopecia areata), and sometimes white re-growth in alopecia areata areas (alopecia-associated leukotrichia).
Distinguishing the two requires dermatological assessment. Dermoscopy of the scalp is useful: alopecia areata shows characteristic patterns (exclamation mark hairs, yellow dots) not seen in vitiligo. A Wood’s lamp examination can confirm the characteristic vitiligo fluorescence in depigmented scalp skin.
Treatment implications: JAK inhibitors (oral baricitinib, upadacitinib; topical ruxolitinib) have evidence for both conditions, which makes them particularly relevant when the two coexist.
Phototherapy for scalp vitiligo
Narrowband UVB phototherapy works for scalp vitiligo, but the hair creates a practical problem — it blocks UV from reaching the scalp skin. To use phototherapy effectively on the scalp:
Part the hair systematically before each session, exposing the scalp skin directly to the lamp. This requires careful technique to ensure coverage without repeatedly exposing already-treated areas.
Use a comb attachment or targeted approach: Some home phototherapy units include comb attachments designed specifically for scalp application. The comb parts hair as it moves, allowing the UV to reach scalp skin. This is significantly more practical than manual parting.
Targeted approaches work better than panel lamps for isolated scalp patches. Excimer laser therapy — a high-intensity targeted UVB device — delivers UV precisely to small areas without requiring the whole scalp to be treated. This is particularly useful for limited scalp involvement where managing a full panel lamp application would be disproportionately complex.
Dose considerations: Hair absorbs some UV, even when parted. Effective UV delivery to scalp skin may require slightly longer exposures than skin treatment elsewhere. If using a home device, the phototherapy safety guide at home phototherapy safety guide covers dosing principles.
Topical treatments
Topical calcineurin inhibitors (tacrolimus, Opzelura) can be applied to the scalp, but application through hair is impractical with standard cream or ointment formulations. Foam or lotion formulations apply better through hair.
Topical corticosteroids in scalp-appropriate formulations (foams, lotions, solutions) are sometimes used, particularly for limited active patches. The same skin-thinning risk with long-term use applies, though the scalp is somewhat more tolerant of steroids than delicate facial skin.
Hair colouring and scalp vitiligo
Many patients with white hair patches want to colour or dye their hair to reduce contrast. Standard hair dye is generally safe to use over vitiligo patches — the chemicals are applied to hair shafts, not skin contact that would affect treatment. The main caution: any scalp irritation from dye can theoretically trigger the Koebner phenomenon (new vitiligo at sites of skin trauma). Patch testing before full application, using gentle formulations, and ensuring the scalp is not inflamed at time of application reduces this risk.
What to expect
Scalp vitiligo with significant leukotrichia is among the harder presentations to repigment. The honest expectation:
- If some hair in the patch remains pigmented: repigmentation is possible with consistent phototherapy or topical treatment, though slower than facial skin
- If all hair in the patch is white and has been for years: repigmentation is unlikely without surgical intervention (melanocyte transplantation to reseed the follicular reservoir)
- Partial responses — some pigmented regrowth among the white hairs — are common even in cases where complete restoration is unlikely
The vitiligo treatment by body area guide gives broader context on how different locations compare in terms of treatment response.
